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OBJECTIVES: The objective of this study was to evaluate the ability of a muscular index (Barrett’s Index), calculated with mul-
tidetector computed tomography, to detect dysthyroid optic neuropathy in patients with Graves’ orbitopathy.
METHODS: Thirty-six patients with Graves’ orbitopathy were prospectively studied and submitted to neuro-ophthalmic evalu-
ation and multidetector computed tomography scans of the orbits. Orbits were divided into two groups: those with and without 
dysthyroid optic neuropathy. Barrett’s index was calculated as the percentage of the orbit occupied by muscles. Sensitivity and 
specificity were determined for several index values. 
RESULTS: Sixty-four orbits (19 with and 45 without dysthyroid optic neuropathy) met the inclusion criteria for the study. The 
mean Barrett’s index values (± SD) were 64.47% ± 6.06% and 49.44% ± 10.94% in the groups with and without dysthyroid optic 
neuropathy, respectively (p<0.001). Barrett’s index sensitivity ranged from 32% to 100%, and Barrett’s index specificity ranged 
from 24% to 100%. The best combination of sensitivity and specificity was 79%/72% for BI=60% (odds ratio: 9.2). 
CONCLUSIONS: Barrett’s Index is a useful indicator of dysthyroid optic neuropathy and may contribute to early diagnosis and 
treatment. Patients with a Barrett’s index ≥60% should be carefully examined and followed for the development of dysthyroid 
optic neuropathy. 
KEYWORDS: Dysthyroid Optic Neuropathy. Multidetector computed tomography. Graves’ Orbitopathy. Visual loss.Thyroid eye 
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INTRODUCTION
Optic nerve dysfunction is a debilitating complication of 
Graves’ orbitopathy (GO) occurring in 5-8.6% of patients,1 
and it is almost always a result of compression of the optic 
nerve at the orbital apex caused by enlarged extraocular 
muscles. Symptoms and signs of dysthyroid optic neuropathy 
(DON) may include decreased visual acuity (VA), abnormal 
visual fields (VF), altered color and brightness perception, 
afferent pupillary defects, and edema or atrophy of the optic 
nerve head.1 When the majority of these symptoms and signs 
are present, the diagnosis of DON is straightforward. It is, 
however, much more difficult to establish when changes in VA 
are subtle since such changes may be related to a number of 
other factors, including decreased corneal transparency due to 
exposure keratopathy.2 Furthermore, many tests for optic nerve 
dysfunction, such as VA, color and brightness perception and 
VF, especially when performed with standard automated 
perimetry (SAP), require full cooperation of an alert and 
motivated patient. Also, such tests will not infrequently render 
false positive results, particularly in patients with congestive 
GO, leading to diagnostic confusion. Objective tests capable 
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of rapidly and accurately identifying patients prone to DON 
development are therefore highly desirable.
Computerized tomography (CT) studies in patients with 
DON often reveal enlargement of extraocular muscles at the 
orbital apex, and several authors have correlated the degree 
of apical crowding on CT scans with optic neuropathy 
in an attempt to raise suspicion of DON and facilitate its 
diagnosis.3-5 In 1988, Barrett et al.5 reported findings for a 
muscular index for CT expected to reflect extraocular muscle 
impingement of the optic nerve in patients with GO. The 
authors calculated the percentage of orbital width occupied 
by muscles (muscular index) from coronal and axial cuts 
halfway between the posterior aspect of the globe and the 
apex of the orbit. A muscular index of 67% or greater was 
reported to be indicative of compressive optic neuropathy.5 
Nevertheless, the difficulties in obtaining perfectly oriented 
coronal cuts and in defining the exact position of the 
coronal cut along the length of the orbit make the technique 
inappropriate for routine use. 
The introduction of multidetector computed tomography 
(MDCT) has resulted in significantly increased scanning 
speed and reduction of artifacts and errors in the evaluation 
of measurements of orbital contents, as the images may be 
reformatted in any plane with high resolution.6 Calculating 
structure indices and volumes is relatively simple and may 
be performed at a workstation connected to the equipment. 
Thus, the purpose of this prospective study was to evaluate 
the value of Barrett’s index (BI) used in combination with 
MDCT as a predictor of DON in patients with GO.
MATERIAL AND METHODS
Between July 2005 and June 2007, 36 patients with 
GO were prospectively studied. GO was diagnosed in 
accordance with previously reported criteria.7 The study 
followed the principles of the Declaration of Helsinki, and 
approval was granted by the Institutional Review Board 
Ethics Committee. All patients underwent a complete 
neuro-ophthalmic examination, including best-corrected 
VA, applanation tonometry, pupillary reactions, extraocular 
motility evaluation, slit lamp examination, evaluation of 
eyelid and soft tissue inflammation, measurement of the 
lid fissure, Hertel exophthalmometry, fundoscopy, and VF 
evaluation. 
VF was performed using manual perimetry and standard 
automated perimetry (SAP). Manual VF testing was 
performed using the Goldmann perimeter (GP) (Haag-
Streit AG, Bern, Switzerland). The V-4-e, I-4-e, I-3-e, I-2-e 
and I-1-e stimuli were used to draw the isopters. Kinetic 
determinations were followed by static presentation of the 
stimuli particularly in the central 30-degree area, in order 
to search for localized defects. SAP was performed with 
a Humphrey field analyzer 750 (Zeiss-Humphrey, Dublin, 
CA) using a 4-mm2 Goldmann size III stimulus (0.43º) on 
a dim background (31.5 apostilb). The central field was 
measured by a threshold 24-2 test program that presents 
stimuli on a 6º-spaced grid encompassing the central 21º of 
the VF (24-2 SITA Standard test). The patients’ appropriate 
near correction was used. Rest breaks were allowed when 
requested. To qualify as an abnormal VF on SAP, three 
adjacent abnormal points at P < 0.05 or two adjacent points 
with one abnormal point at P < 0.01 were required.8 
Both orbits of each patient were scanned on a 16-slice 
MDCT scanner (Brilliance 16; Philips Medical Systems, 
Nederland B.V., the Netherlands) without the use of 
sedation or intravenous contrast. Scanning was performed 
with the patients’ eyes closed and immobile. The MDCT 
scan parameters were: Kv = 120; mAs = 200; detector 
configuration = 16 x 0.75 mm; slice thickness = 1.5 mm; 
image spacing = 0.7 mm. We used the method described 
by Barrett et al.5 to generate a muscular index capable of 
quantifying extraocular muscle impingement on the optic 
nerve. A reformatted coronal scan halfway between the 
posterior globe and the orbital apex was used to calculate 
the muscular index. The transverse dimensions of the medial 
rectus muscle (A), the lateral rectus muscle (B), and the 
orbital width (C) were measured along a horizontal line 
through the optic nerve. The horizontal muscular index was 
calculated as the percentage of orbital width occupied by 
the lateral and medial rectus muscles [(A+B/C).100] (Figure 
1). The vertical muscle index was based on the vertical 
dimensions of the superior rectus/levator muscle complex 
(D), the inferior rectus muscle (E), and the orbital height (F) 
[(D+E/F).100] (Figure 1). The larger value was considered 
the muscular index, corresponding to the Barrett Index (BI), 
and was used in subsequent data analysis5. Measurements 
were made by an examiner that was not aware of the 
presence or absence of optic neuropathy. 
Figure 1 - Schematic representation of the method for calculating Barrett’s 
Index. The vertical index is calculated by the sum of the vertical muscle 
diameters (A and B) divided by the vertical dimension of the orbit (C). The 
horizontal index is calculated by dividing the sum of the horizontal muscle 
diameters (D and E) by the horizontal diameter of the orbit (F). 
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Sixty-four of the 72 orbits scanned were selected for 
the study. Orbits of eyes with GO and visual function data 
clearly indicating the presence or absence of active DON 
were eligible. The diagnostic criteria for DON were the 
presence of a relative afferent pupillary defect and the 
presence of a confirmed VF defect on SAP or GP associated 
or not with diminished best-corrected VA not caused by 
changes in transparency. When VA was normal and VF 
abnormalities were present on SAP, a repeat examination 
using SAP or GP was performed to rule out false positive 
responses. Thus, only eyes with confirmed VF defects 
were included in the analysis. Eyes with normal VA and 
nonreproducible VF abnormalities upon repeat examinations 
were excluded. Patients with ocular or optic nerve diseases 
that prevented the correct diagnosis of DON were also 
excluded. All patients with DON had an active disease, 
but less than four weeks of onset of visual disturbance and 
clinical signs of orbital congestive disease. 
The sensitivity and specificity of BI for identifying eyes 
with DON was calculated in the conventional manner. A 
criterion with a high specificity, if positive, “rules in” the 
disease, and a test with a high sensitivity, if negative, “rules 
out” the disease.9 After carefully determining the presence or 
absence of DON, we calculated the sensitivity and specificity 
(with 95% confidence interval) for a number of pre-defined 
criteria for BI index values, including 40%, 50%, 60%, 67%, 
and 70%. The odds ratio for having DON was calculated for 
each of these values. 
We used an unpaired t-test for comparisons between 
groups of orbits with and without DON and Fisher’s 
exact test for evaluating the significance of sensitivity and 
specificity values. Adherence to normal distribution was 
assessed using the Shapiro-Wilk test. P values of less than 
0.05 were considered significant. 
RESULTS
Sixty-four orbits from 36 patients with GO were included 
in the analysis. Nineteen of these were from 12 patients (7 
women and 5 men; mean age ± SD: 53.3 ± 10.4 years) who 
met the diagnostic criteria for DON. Seven patients had 
bilateral DON, and both orbits were included in the study. 
Five patients had only one orbit included in the group of 
DON; in two patients, the contralateral eye did not meet 
the criteria for DON; two patients had the contralateral eye 
excluded, since the presence or absence of DON could not 
be clearly determined; one patient had a history of central 
retinal artery occlusion unrelated to GO, which led to our 
exclusion of the contralateral eye. Forty-five orbits were 
affected with GO but not with DON; two of these were from 
patients with DON in the contralateral eye, while 43 were 
from 24 patients (17 women and 7 men; mean age ± SD: 
45.5 ± 15.2 years) with DON absent in both eyes. Five orbits 
in this group were excluded from the study: in three, the 
diagnosis of GO could not be established (unilateral GO); in 
one the eye was deviated in an extreme upward position, and 
therefore it was not possible to determine either the presence 
or absence of DON; and in one an old orbital fracture was 
observed. 
Of the 19 orbits of eyes with DON, VA was 1.0 in 11, 0.9 
in 4, 0.8 in 3 and 0.6 in one. The mean (± SD) of SAP mean 
deviation was -7.48 ± 5.26 dB. Results from the glaucoma 
hemifield test were outside the normal range in 16 eyes and 
borderline in three. Exophthalmometry measurements in 
affected eyes ranged from 19 to 30 mm (mean ± SD: 24.66 
± 3.08 mm). Restrictive myopathy was present in all orbits 
with DON. Fundoscopic examination revealed optic disc 
edema in a single eye and no abnormalities in the remainder 
of the eyes. In the group without DON, VA was 1.0 in all 
eyes and exophthalmometry findings ranged from 20.0 to 
28.0 mm (mean ± SD: 23.2 ± 2.1). 
The mean BI ± SD for the groups with and without DON 
was 62.67% ± 8.14% and 49.44% ± 10.94%, respectively 
(p < 0.001). Table 1 shows the relative frequency of orbits 
calculated with BI values of 40%, 50%, 60%, 67%, and 70% 
in the 64 orbits studied. Table 2 summarizes the sensitivity 
and specificity for the respective BI values. The sensitivity 
ranged from 32% to 100%, and the specificity ranged from 
24% to 100%. The odds ratio was statistically significant for 
all values of BI values tested (Table 2). The best combination 
of sensitivity/specificity was 79%/72% for BI=60%, yielding 
an odds ratio of 9.2. 
DISCUSSION
DON requires prompt diagnosis and treatment in order to 
prevent permanent damage to the visual function. Although 
DON can most often be diagnosed on clinical grounds based 
on visual function assessment, the presence of an afferent 
Table 1 - Relative frequency of orbits according to Barrett’s 
Index, in 64 orbits with Graves’ Orbitopathy (GO) with and 
without dysthyroid optic neuropathy (DON)
Barrett Index GO with DON 
(n = 19 )
GO without DON 
(n= 45)
40% 19 (100.0%) 34 (75.6%)
50% 19 (100.0%) 23 (51.1%)
60% 15 (78.9%) 13 (28.9%)
67% 8 (38.1%) 2 (4.4%)
70% 6 (28.6%) 0 (0%)
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pupillary defect and fundoscopic abnormalities such as 
disc edema and choroidal folds, the diagnosis of DON can 
be difficult in many cases. The uncertainty in the diagnosis 
occurs mainly in non-cooperative patients or those who 
have difficulties in performing psychophysical tests such 
as SAP, which is particularly common in anxious patients 
with marked proptosis, lid retraction, and profuse tearing. 
Therefore, additional objective data such as imaging findings can 
be very helpful in the diagnosis. 
Although inflammatory and vascular mechanisms have also 
been suggested, the most widely accepted mechanism of optic 
neuropathy suggests that pathologically enlarged extraocular 
muscles compress the optic nerve at the orbital apex. In fact, several 
authors have documented the relationship between DON and the 
size of the extraocular muscles as measured by CT.3, 5, 10-14 Other 
imaging features reflecting an increased volume of orbital contents, 
such as proptosis and apical crowding, have also been shown to 
be more common in patients with optic neuropathy.1, 4, 14 Birchall 
et al.15 suggested that CT evidence of fat herniating through the 
superior ophthalmic fissure would be a useful indicator of DON. 
However, in recent reports by McKeag et al.,16 they observed this 
condition in only 40 of 94 eyes with DON, suggesting that it would 
have a low sensitivity as an indicator of DON. A gradation of apical 
crowding has been described by Nugent et al.4 These authors found 
apical crowding greater than 50% to be a useful indicator of DON, 
with a sensitivity of 66% and a specificity of 87%. McKeag et 
al.16 confirmed the usefulness of this indicator in a report of apical 
crowding greater than 50% in 78 of 98 eyes with DON. However, 
it should noted that measuring apical crowding or the muscle 
occupation tax at the orbital apex is often a cumbersome task, since 
the muscle limits can be difficult to identify. Extraocular muscles, 
the superior orbital vein, and the optic nerve are frequently indistinct 
at the orbital apex even when high resolution CT is used. 
Barrett et al.5 described what is probably the easiest and most 
reproducible method for correlating the degree of extraocular 
muscle enlargement with the development of DON: a muscular 
index calculated as the percentage of orbital width occupied by 
vertical and horizontal muscles in relation to orbital dimensions 
as measured from the midpoint between the globe and the orbital 
apex. In a retrospective study, the authors concluded that a muscular 
index of 67%, as encountered in 12 of 49 orbits evaluated, would 
be virtually diagnostic of DON. Recently, in another retrospective 
study evaluating an index of 67%, Giaconi et al.14 found that 55% 
of orbits with DON and six out of 34 orbits without DON met the 
criterion. All 20 orbits affected with DON presented a muscular 
index greater than 50%. In another retrospective study, Birchall et 
al.15 reported a sensitivity of 50% and a specificity of 73% for BI 
of 50%. These authors observed that only one of the 17 orbits with 
DON had BI of 67%, a result very different from those observed 
by Barrett et al.,5 probably as a result of the inclusion of milder 
cases of DON. 
To our knowledge, this is the first prospective study using 
MDCT to investigate the sensitivity and specificity of BI. Since 
MDCT can achieve very accurate reformations in the coronal 
plane, with a clear definition of the position along the orbit, we 
believe that the study shows a significant improvement in quality 
and reproducibility, compared to previous reports. Furthermore, 
in our study patients were carefully and prospectively evaluated 
for the presence or absence of DON. Our results indicate that if a 
percentage of 67% is required for diagnosis, as suggested by Barrett 
et al.,5 DON would be identified in only 8 out of 19 affected orbits. 
Moreover, two orbits without DON met the criterion, despite careful 
evaluation with SAP indicating absence of VF abnormalities. Thus, 
a muscular index of 67% presented a sensitivity of only 42% and 
a specificity of 96%. In our study, when lower values of BI were 
tested, we observed a significant increase in sensitivity with a 
corresponding decrease in specificity. For example, when BI was 
40%, the sensitivity was 100% and the specificity, 24%; with BI = 
50%, the sensitivity was 100% and the specificity, 49%; with BI = 
60%, the sensitivity was 79% and the specificity, 72%. Finally, for 
higher BI values, such as 70%, we have found a sensitivity of 32% 
and a specificity of 100%. The best combination for sensitivity/
specificity was therefore observed with BI = 60%. With this index, 
the odds ratio for the presence of DON was 9.2 (95% confidence 
interval; 2.66 - 31.57). 
Our study indicates a BI of 67% is neither required for nor an 
Table 2 - The sensitivity, specificity and odds ratios with confidence intervals (CI) of several levels of Barrett’s index for 
the diagnosis of 19 orbits with dysthyroid optic neuropathy and of 45 orbits of patients with Graves’ Orbitopathy without 
dysthyroid optic neuropathy
Barrett’s Index Sensitivity (95% CI) Specificity (95% CI) Odds Ratio P*
40% 1.0 (0.87-1.00) 0.24 (0.19-0.24) Inf (1.51- Inf) 0.025
50% 1.0 (0.86-1.00) 0.49 (0.43-0.49) Inf (4.49-Inf) < 0.001
60% 0.79 (0.61-0.91) 0.72(0.64-0.76) 9.2 (2.66-31.57) < 0.001
67% 0.42 (0.27-0,49) 0.96 (0.89-0.99) 15.6 (3.19-73.97) 0.001
70% 0.32 (0.20-0.32) 1.0 (0.95-1.00) Inf (4.95-Inf) < 0.001
* Fisher’s exact test. Significant values are in italics. Inf = infinity.
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absolute indicator of the presence of DON. However, it is important 
to consider that BI could also vary depending on the severity of the 
neuropathy. For example, Guy et al.17 considered DON to be severe 
when visual acuity was equal to or worse than 20/80. Because we 
included patients with milder forms of DON, it is understandable 
that some of the subjects presented lower BI values. Furthermore, 
because BI is measured on the orbit halfway between the globe 
and the optic canal, it is likely that diagnoses in some patients with 
predominantly apical muscle enlargement are missed. Finally, 
it is important to point out that, although extraocular muscle 
enlargement is the most likely mechanism for the development 
of visual loss in DON, unusual cases of DON without extraocular 
muscle enlargement have been reported.18 
Despite these limitations, we believe BI can be helpful when 
screening for DON because it is easily calculated for patients with 
GO submitted to MDCT. Our findings indicate that patients with a 
muscular index greater than 60% should be carefully examined for 
the presence of DON. Although high index values may be found 
in some patients with GO and normal visual function, the great 
majority of cases will have values associated with DON, and thus 
this assessment may contribute to early diagnosis and treatment.
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